United Kingdom · Question · Written question
UIN 396
Voluntary Scheme for Branded Medicines Pricing and Access
Original
Introduced
7 November 2023
Last action
5 December 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
5 December 2023
Summary
To ask the Secretary of State for Health and Social Care, with reference to Association of the British Pharmaceutical Industry’s publication entitled At the crossroads: how a new UK medicines deal can deliver for patients, the NHS and the economy, publish
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
7 November 2023
Written question
To ask the Secretary of State for Health and Social Care, with reference to Association of the British Pharmaceutical Industry’s publication entitled At the crossroads: how a new UK medicines deal can deliver for patients, the NHS and the economy, publish
Source: Commons
5 December 2023
Answer
The Department carefully considers all evidence in the public domain on matters relating to the pricing of medicines in the United Kingdom, including the March report by the Association of the British Pharmaceutical Industry (ABPI). The Voluntary Scheme f...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-11-07/396
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1668015
- uk · wq-1668015 · source updated 5 December 2023